In line with an essential role of tumor IFN-γ signaling in tumor antigen presentation14, we noticed a drastic reduction of MHC molecules in IFNγR1KO cells (Fig. 1j), suggesting an inefficient process of T cell cross-priming in IFNγR1KO melanomas. The gene discussed is IFNG; the disease is melanoma.